Navigation Links
Tandem Diabetes Care Announces Closing of Initial Public Offering
Date:11/19/2013

SAN DIEGO, Nov. 19, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced the closing of its initial public offering of 9,200,000 shares of common stock at a price of $15.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 1,200,000 shares.  All of the shares in the offering were offered by Tandem. Tandem's common stock is listed on the NASDAQ Global Market under the ticker symbol "TNDM."  

BofA Merrill Lynch and Piper Jaffray acted as joint book-running managers for the offering. Deutsche Bank Securities and Stifel acted as co-managers.  

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (SEC) on November 13, 2013.  A copy of the final prospectus relating to the offering may be obtained from: BofA Merrill Lynch, 222 Broadway, New York, NY 10038 Attention: Prospectus Department, by email at dg.Prospectus_Requests@baml.com; or Piper Jaffray & Co., Attention: Equity Capital Markets, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at 800-747-3924 or by email at prospectus@pjc.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The Company manufactures and sells the t:slim Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the first and only insulin pump with a high resolution, color touch screen. Tandem is based in San Diego, California.


'/>"/>
SOURCE Tandem Diabetes Care, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Initial Public Offering of Common Stock
2. Tandem Diabetes Care Prices Initial Public Offering
3. TANDEM DIABETES CARE BECOMES PRESENTING SPONSOR OF THE GREATEST AWARDS SHOW IN DIABETES
4. Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
5. Tandem Diabetes Care Names Lonnie Smith As Chairman Of The Board
6. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
7. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
8. Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical
9. Bone-Breaking News: Mayo Clinic Solves Mysterious Link Between Diabetes and Osteoporosis
10. Lilly Announces Significant Global Insulin Manufacturing Capacity Investments in Response to Growing Diabetes Epidemic
11. Organogenesis Launches Fight4MyFeet for Diabetes Patient and Healthcare Provider Communities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 /PRNewswire/ ... through a data-driven, biological research approach, today ... contributed to the discovery of new data ... and facilitate brown fat metabolism. Joslin Diabetes ... its Interrogative Biology® platform for analysis of ...
(Date:3/27/2017)... -- On Friday, benchmark US indices were ... trading session up 0.19%; the Dow Jones Industrial Average ... 0.08%. US markets made broad based gains with five ... Pre-market today, Stock-Callers.com reviews these four Medical Appliances & ... Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: MDXG), and ...
(Date:3/27/2017)... , March 27, 2017  Allergan plc, ... Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company ... therapies based upon tetracycline chemistry, announced that two ... treatment of moderate to severe acne met their ... once-daily, oral, narrow spectrum tetracycline-derived antibiotic with anti-inflammatory ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and ... high-quality results and maintaining GMP and USP compliance. In a new webinar from ... GMP requirements " these requirements are explained. The challenge is to determine ...
(Date:3/28/2017)... ... 28, 2017 , ... Neurotechnology , a provider of ... attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the ... face recognition to enable users to check in and out from anywhere via ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the Self-Funding Success website has recently developed and published an informational resource that ... was created based on common inquiries the site’s team of third party administrator ...
(Date:3/28/2017)... ... ... A minimally invasive porcelain veneer is increasing in popularity ... Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive dentistry, ... and technicians that create these veneers. , According to National Board for ...
Breaking Medicine News(10 mins):